The Impact of Visiting Restrictions During the COVID-19 Pandemic on Pediatric Patients

Deborah L McBride1

  • 1Samuel Merritt University, CA, USA.

Journal of Pediatric Nursing
|September 20, 2021
PubMed

Insights

Hospital visitor restrictions due to COVID-19 disproportionately impact children. More research is needed on the long-term effects of this separation on pediatric patients and their families.

Area of Science:

  • Pediatric healthcare
  • Public health policy
  • Infectious disease control

Background:

  • COVID-19 pandemic necessitated hospital visitor restrictions to mitigate virus transmission.
  • These policies are crucial for hospital infection control strategies.
  • Existing research on visitor restrictions primarily focuses on adult patients.

Purpose of the Study:

  • To examine the impact of COVID-19 visitor restrictions on hospitalized pediatric patients.
  • To address the gap in primary research regarding the effects on children and their caregivers.
  • To highlight the disproportionate effect of these policies on pediatric populations.

Main Methods:

  • This study highlights a gap in primary research.
  • It emphasizes the need for future research into pediatric patient experiences.
  • Qualitative and quantitative methodologies are suggested for future studies.

Main Results:

  • Visitor restriction policies significantly affect hospitalized children.
  • The absence of family at the bedside can cause distress and trauma to pediatric patients.
  • Caregivers also experience significant emotional and psychological burden due to separation.

Conclusions:

  • COVID-19 visitor restrictions have a profound and disproportionate impact on pediatric patients.
  • There is an urgent need for further investigation into the long-term consequences for children and their families.
  • Future research should inform policy adjustments to better support pediatric patients during health crises.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
38
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
35